Selected research
Market Structure
Global Human Serum and Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Human Serum and Plasma market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Human Serum and Plasma include Thermo Fisher, Merck Millipore, Baxter, Zen-Bio, Trina Bioreactives, TCS Biosciences Ltd, SeraCare, Monobind and Cytiva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Human Serum and Plasma output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Human Serum and Plasma by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Human Serum and Plasma market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Human Serum and Plasma and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Human Serum and Plasma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Serum and Plasma market size, projected growth trends, production technologies, key applications, and end-use industries.
Human Serum and Plasma Segment by Company
Thermo Fisher
Merck Millipore
Baxter
Zen-Bio
Trina Bioreactives
TCS Biosciences Ltd
SeraCare
Monobind
Cytiva
Akron
Human Serum and Plasma Segment by Type
Fresh Human Serum and Plasma
Frozen Human Serum and Plasma
Human Serum and Plasma Segment by Application
Vaccines and Antibodies
Cell Culture
In Vitro Diagnostics
Clinical Research
Others
Human Serum and Plasma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum and Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Serum and Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Serum and Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Serum and Plasma market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Serum and Plasma industry.
Chapter 3: Detailed analysis of Human Serum and Plasma market competition landscape. Including Human Serum and Plasma manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Human Serum and Plasma by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Human Serum and Plasma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fresh Human Serum and Plasma
- Frozen Human Serum and Plasma
Applications
- Vaccines and Antibodies
- Cell Culture
- In Vitro Diagnostics
- Clinical Research
- Others
Companies covered
- Thermo Fisher
- Merck Millipore
- Baxter
- Zen-Bio
- Trina Bioreactives
- TCS Biosciences Ltd
- SeraCare
- Monobind
- Cytiva
- Akron
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Human Serum and Plasma Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Human Serum and Plasma Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Human Serum and Plasma Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Human Serum and Plasma Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Human Serum and Plasma Market Dynamics
- 2.1 Human Serum and Plasma Industry Trends
- 2.2 Human Serum and Plasma Industry Drivers
- 2.3 Human Serum and Plasma Industry Opportunities and Challenges
- 2.4 Human Serum and Plasma Industry Restraints
3 Human Serum and Plasma Market by Manufacturers
- 3.1 Global Human Serum and Plasma Production Value by Manufacturers (2021-2026)
- 3.2 Global Human Serum and Plasma Production by Manufacturers (2021-2026)
- 3.3 Global Human Serum and Plasma Average Price by Manufacturers (2021-2026)
- 3.4 Global Human Serum and Plasma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Human Serum and Plasma Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Human Serum and Plasma Manufacturers, Product Type & Application
- 3.7 Global Human Serum and Plasma Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Human Serum and Plasma Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Human Serum and Plasma Players Market Share by Production Value in 2025
- 3.8.3 2025 Human Serum and Plasma Tier 1, Tier 2, and Tier 3
4 Human Serum and Plasma Market by Type
- 4.1 Human Serum and Plasma Type Introduction
- 4.1.1 Fresh Human Serum and Plasma
- 4.1.2 Frozen Human Serum and Plasma
- 4.2 Global Human Serum and Plasma Production by Type
- 4.2.1 Global Human Serum and Plasma Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Human Serum and Plasma Production by Type (2021-2032)
- 4.2.3 Global Human Serum and Plasma Production Market Share by Type (2021-2032)
- 4.3 Global Human Serum and Plasma Production Value by Type
- 4.3.1 Global Human Serum and Plasma Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Human Serum and Plasma Production Value by Type (2021-2032)
- 4.3.3 Global Human Serum and Plasma Production Value Market Share by Type (2021-2032)
5 Human Serum and Plasma Market by Application
- 5.1 Human Serum and Plasma Application Introduction
- 5.1.1 Vaccines and Antibodies
- 5.1.2 Cell Culture
- 5.1.3 In Vitro Diagnostics
- 5.1.4 Clinical Research
- 5.1.5 Others
- 5.2 Global Human Serum and Plasma Production by Application
- 5.2.1 Global Human Serum and Plasma Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Human Serum and Plasma Production by Application (2021-2032)
- 5.2.3 Global Human Serum and Plasma Production Market Share by Application (2021-2032)
- 5.3 Global Human Serum and Plasma Production Value by Application
- 5.3.1 Global Human Serum and Plasma Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Human Serum and Plasma Production Value by Application (2021-2032)
- 5.3.3 Global Human Serum and Plasma Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher
- 6.1.1 Thermo Fisher Company Information
- 6.1.2 Thermo Fisher Business Overview
- 6.1.3 Thermo Fisher Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Human Serum and Plasma Product Portfolio
- 6.1.5 Thermo Fisher Recent Developments
- 6.2 Merck Millipore
- 6.2.1 Merck Millipore Company Information
- 6.2.2 Merck Millipore Business Overview
- 6.2.3 Merck Millipore Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.2.4 Merck Millipore Human Serum and Plasma Product Portfolio
- 6.2.5 Merck Millipore Recent Developments
- 6.3 Baxter
- 6.3.1 Baxter Company Information
- 6.3.2 Baxter Business Overview
- 6.3.3 Baxter Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.3.4 Baxter Human Serum and Plasma Product Portfolio
- 6.3.5 Baxter Recent Developments
- 6.4 Zen-Bio
- 6.4.1 Zen-Bio Company Information
- 6.4.2 Zen-Bio Business Overview
- 6.4.3 Zen-Bio Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.4.4 Zen-Bio Human Serum and Plasma Product Portfolio
- 6.4.5 Zen-Bio Recent Developments
- 6.5 Trina Bioreactives
- 6.5.1 Trina Bioreactives Company Information
- 6.5.2 Trina Bioreactives Business Overview
- 6.5.3 Trina Bioreactives Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.5.4 Trina Bioreactives Human Serum and Plasma Product Portfolio
- 6.5.5 Trina Bioreactives Recent Developments
- 6.6 TCS Biosciences Ltd
- 6.6.1 TCS Biosciences Ltd Company Information
- 6.6.2 TCS Biosciences Ltd Business Overview
- 6.6.3 TCS Biosciences Ltd Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.6.4 TCS Biosciences Ltd Human Serum and Plasma Product Portfolio
- 6.6.5 TCS Biosciences Ltd Recent Developments
- 6.7 SeraCare
- 6.7.1 SeraCare Company Information
- 6.7.2 SeraCare Business Overview
- 6.7.3 SeraCare Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.7.4 SeraCare Human Serum and Plasma Product Portfolio
- 6.7.5 SeraCare Recent Developments
- 6.8 Monobind
- 6.8.1 Monobind Company Information
- 6.8.2 Monobind Business Overview
- 6.8.3 Monobind Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.8.4 Monobind Human Serum and Plasma Product Portfolio
- 6.8.5 Monobind Recent Developments
- 6.9 Cytiva
- 6.9.1 Cytiva Company Information
- 6.9.2 Cytiva Business Overview
- 6.9.3 Cytiva Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.9.4 Cytiva Human Serum and Plasma Product Portfolio
- 6.9.5 Cytiva Recent Developments
- 6.10 Akron
- 6.10.1 Akron Company Information
- 6.10.2 Akron Business Overview
- 6.10.3 Akron Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 6.10.4 Akron Human Serum and Plasma Product Portfolio
- 6.10.5 Akron Recent Developments
7 Global Human Serum and Plasma Production by Region
- 7.1 Global Human Serum and Plasma Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Human Serum and Plasma Production by Region (2021-2032)
- 7.2.1 Global Human Serum and Plasma Production by Region (2021-2026)
- 7.2.2 Global Human Serum and Plasma Production Forecast by Region (2027-2032)
- 7.3 Global Human Serum and Plasma Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Human Serum and Plasma Production Value by Region (2021-2032)
- 7.4.1 Global Human Serum and Plasma Production Value by Region (2021-2026)
- 7.4.2 Global Human Serum and Plasma Production Value by Region (2027-2032)
- 7.5 Global Human Serum and Plasma Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Human Serum and Plasma Production Value (2021-2032)
- 7.6.2 Europe Human Serum and Plasma Production Value (2021-2032)
- 7.6.3 Asia-Pacific Human Serum and Plasma Production Value (2021-2032)
- 7.6.4 South America Human Serum and Plasma Production Value (2021-2032)
- 7.6.5 Middle East & Africa Human Serum and Plasma Production Value (2021-2032)
8 Global Human Serum and Plasma Consumption by Region
- 8.1 Global Human Serum and Plasma Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Human Serum and Plasma Consumption by Region (2021-2032)
- 8.2.1 Global Human Serum and Plasma Consumption by Region (2021-2026)
- 8.2.2 Global Human Serum and Plasma Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Human Serum and Plasma Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Human Serum and Plasma Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Human Serum and Plasma Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Human Serum and Plasma Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Human Serum and Plasma Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Human Serum and Plasma Value Chain Analysis
- 9.1.1 Human Serum and Plasma Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Human Serum and Plasma Production Mode & Process
- 9.2 Human Serum and Plasma Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Human Serum and Plasma Distributors
- 9.2.3 Human Serum and Plasma Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst